NCT05767827View on ClinicalTrials.gov

Effect of Dexmedetomidine As Adjuvant to Ropivacaine for Brachial Plexus Block

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

July 30, 2023

Study Completion Date

August 30, 2024

Conditions
Local Anesthesia AdjuvantsUpper Extremity FractureBrachial Plexus Block
Interventions
DRUG

ropivacaine, lidocaine with adrenaline

Group R includes 0.35% ropivacaine 20ml, 1.5 % lidocaine with adrenaline 10ml

DRUG

Dexmedetomidine, ropivacaine, lidocaine with adrenaline

Dexmedetomidine 1mcg/kg and 0.35% ropivacaine with normal saline (20ml), 1.5% lidocaine with adrenaline (10ml) in group RD

Trial Locations (1)

0096

Nepal medical college, Kathmandu

All Listed Sponsors
lead

Nepal Medical College and Teaching Hospital

OTHER